Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/18551

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorDoi, K.-
dc.contributor.authorHonjo, K.-
dc.contributor.authorDoi, C.-
dc.contributor.authorMitsuoka, T.-
dc.date.accessioned2011-02-02T14:59:28Z-
dc.date.available2011-02-02T14:59:28Z-
dc.date.issued1990-
dc.identifier.issn0213-3911-
dc.identifier.urihttp://hdl.handle.net/10201/18551-
dc.description.abstractEffects of cyclophosphamide (CY) on the antibody titer level and incidence and severity of swine serum (SS)-induced bile duct lesion (BDL) were examined. BDL induced by 0.2 m1 of SS per head twice a week for 2 weeks was characterized by hyperplasia of biliary epithelial cells, proliferation of mucous glands, and periductal infiltration of eosinophils with mild fibrosis. CY showed no significant influence on the above-mentioned parameters at the dose levels of 140 and 210 mg/kg. On the other hand, CY lowered the antibody titer level and decreased the seventy of BDL at the dose level of 280 mg/kg, and it suppressed the antibody response and BDL at the dose level of 280 X 2 mg/kg. Thus the antibody titer level and the severity of BDL were closely related each other.es
dc.formatapplication/pdfes
dc.format.extent5es
dc.languageenges
dc.publisherMurcia: F. Hernándezes
dc.relation.ispartofHistology and histopathology, vol. 5, nº2 (1990)es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectSwine serumes
dc.subjectCyclophosphamidees
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes
dc.titleModification of swine serum-induced bile duct lesion in BALB/c mice by cyclophosphamidees
dc.typeinfo:eu-repo/semantics/articlees
Aparece en las colecciones:Vol. 5, nº 2 (1990)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
139-143 Modification of swine serum-induced bile duct lesion in BALBIc mice by cyclophosphamide.pdf490,1 kBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.